SCHEMBL16270337

SCHEMBL16270337

Cc1ccc(CNC(=O)NCC(=O)NCCN2CCCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.58
▸ CYP2D6 P10635 3/20 0.58
▸ TSHR P16473 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ KMT2A Q03164 4/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ POLB P06746 1/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ FPR3 P25089 1/20 0.50
▸ FPR2 P25090 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ CACNA1G O43497 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ HPGD P15428 2/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ NAMPT P43490 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12643847 0.88 PPID (0.63) CYP2D6KMT2AMEN1POLBSMN1; SMN2
SCHEMBL12993899 0.80 KMT2A (0.64) CYP3A4CYP2D6TSHRCYP2C19KMT2A
SCHEMBL15832190 0.79 PPID (0.73) CYP3A4CYP2C19KMT2AMEN1SMN1; SMN2
SCHEMBL14679142 0.78 HPGD (0.69) CYP3A4CYP2D6TSHRCYP2C19KMT2A
SCHEMBL15832157 0.78 PPID (0.75) KMT2AMEN1SMN1; SMN2HPGDRAB9A
SCHEMBL13102979 0.77 HPGD (0.71) CYP3A4CYP2D6TSHRCYP2C19KMT2A
SCHEMBL23898822 0.76 CA1 (0.62) CYP3A4CYP2D6TSHRCYP2C19KMT2A
SCHEMBL14617667 0.76 SMN1; SMN2 (0.81) CYP2C19KMT2AMEN1SMN1; SMN2GAA
SCHEMBL14617672 0.75 SMN1; SMN2 (0.70) KMT2AMEN1SMN1; SMN2HPGDRAB9A
SCHEMBL13065455 0.75 GAA (0.67) CYP3A4CYP2D6TSHRCYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8901295-B2 Inhibitors of cyclophilins and uses thereof INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2014-12-02 — — US disclosed
Send feedback